Barrett’s esophagus may develop into esophageal cancer. Not all Barrett’s esophagus requires surgical resection, and treatment measures such as endoscopic resection, radiofrequency ablation, and close monitoring and follow up should be comprehensively selected based on endoscopic or pathological examination.
Barrett’s esophagus is one of the complications of gastroesophageal reflux disease (GERD). Pathologic findings of Barrett’s esophagus mucosa include several types, including no heterozygous hyperplasia, low-grade heterozygous hyperplasia, high-grade heterozygous hyperplasia, and esophageal adenocarcinoma.
For early Barrett’s esophagus adenocarcinoma and high-grade heterozygosis, microscopic radical surgical resection and biopsy of the surrounding lymph nodes are recommended; for Barrett’s esophagus patients with low-grade heterozygosis, endoscopic resection or radiofrequency ablation is recommended; for Barrett’s esophagus patients with untreatable non-heterozygous hyperplasia, they may be closely monitored temporarily with follow-up visits once every six months.
If Barrett’s esophagus is detected, it is recommended to go to the hospital in time.